Product Information
GLIPIZIDE 5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0351 per EA under NDC 72888011605. Its NADAC has been published 95 times since Sep 4, 2024.
Strength
5 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888011605
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GLIPIZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214874On Market Since
10/3/2023
Pharmacological Classes
Price Statistics
The NADAC for GLIPIZIDE 5 MG TABLET has been published 95 times since Sep 4, 2024, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0351 per EA |
|---|---|
| All-time high | $0.0360 (May 13, 2026) |
| All-time low | $0.0252 (Nov 20, 2024) |
| 52-week high | $0.0360 |
| 52-week low | $0.0342 |
| Median price | $0.0345 |
| Average price | $0.0339 |
| Largest weekly change | -26.1% (Nov 20, 2024) |
| Weeks tracked | 95 |
| Tracking since | Sep 4, 2024 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GLIPIZIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE 5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0351 per EA (NDC 72888011605), effective Jun 24, 2026.
How has the price of GLIPIZIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLIPIZIDE 5 MG TABLET has risen 3.3%. It has been tracked across 95 weekly CMS publications since Sep 4, 2024.
What are the highest and lowest recorded NADAC prices for GLIPIZIDE 5 MG TABLET?
Since Sep 4, 2024, the NADAC for GLIPIZIDE 5 MG TABLET has ranged from a low of $0.0252 (Nov 20, 2024) to a high of $0.0360 (May 13, 2026), with a median of $0.0345 per EA.
Are there cheaper alternatives to GLIPIZIDE 5 MG TABLET?
12 NADAC-published products share the same active ingredient, strength, and dosage form as GLIPIZIDE 5 MG TABLET, but none are currently priced below it.
Who manufactures GLIPIZIDE 5 MG TABLET?
GLIPIZIDE 5 MG TABLET (NDC 72888011605) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification